3-[6-[2-[1-(3H-dibenzofuran-3-id-2-yl)pyrazol-3-yl]propan-2-yl]-2-pyridinyl]-2,6-difluoro-4H-pyridin-4-ide;2,6-difluoro-3-[6-[1-[1-(2H-naphthalen-2-id-1-yl)pyrazol-3-yl]cyclopentyl]-2-pyridinyl]-4H-pyridin-4-ide;2,6-difluoro-3-[6-[1-phenyl-1-[1-[3-(trifluoromethyl)benzene-6-id-1-yl]pyrazol-3-yl]ethyl]-2-pyridinyl]-4H-pyridin-4-ide;3-[2-[6-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2-pyridinyl]propan-2-yl]-1-phenylindazole;pentakis(platinum(2+));2-(4H-pyridin-4-id-3-yl)-6-[2-[4-(trifluoromethyl)-1-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazol-3-yl]propan-2-yl]pyridine
C134H89F17N20OPt5 — CID 157434277
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[6-[2-[1-(3H-dibenzofuran-3-id-2-yl)pyrazol-3-yl]propan-2-yl]-2-pyridinyl]-2,6-difluoro-4H-pyridin-4-ide;2,6-difluoro-3-[6-[1-[1-(2H-naphthalen-2-id-1-yl)pyrazol-3-yl]cyclopentyl]-2-pyridinyl]-4H-pyridin-4-ide;2,6-difluoro-3-[6-[1-phenyl-1-[1-[3-(trifluoromethyl)benzene-6-id-1-yl]pyrazol-3-yl]ethyl]-2-pyridinyl]-4H-pyridin-4-ide;3-[2-[6-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2-pyridinyl]propan-2-yl]-1-phenylindazole;pentakis(platinum(2+));2-(4H-pyridin-4-id-3-yl)-6-[2-[4-(trifluoromethyl)-1-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazol-3-yl]propan-2-yl]pyridine
3-[6-[2-[1-(3H-dibenzofuran-3-id-2-yl)pyrazol-3-yl]propan-2-yl]-2-pyridinyl]-2,6-difluoro-4H-pyridin-4-ide;2,6-difluoro-3-[6-[1-[1-(2H-naphthalen-2-id-1-yl)pyrazol-3-yl]cyclopentyl]-2-pyridinyl]-4H-pyridin-4-ide;2,6-difluoro-3-[6-[1-phenyl-1-[1-[3-(trifluoromethyl)benzene-6-id-1-yl]pyrazol-3-yl]ethyl]-2-pyridinyl]-4H-pyridin-4-ide;3-[2-[6-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2-pyridinyl]propan-2-yl]-1-phenylindazole;pentakis(platinum(2+));2-(4H-pyridin-4-id-3-yl)-6-[2-[4-(trifluoromethyl)-1-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazol-3-yl]propan-2-yl]pyridine (PubChem CID 157434277) has the molecular formula C134H89F17N20OPt5 and a molecular weight of 3293.68 g/mol. Its IUPAC name is 3-[6-[2-[1-(3H-dibenzofuran-3-id-2-yl)pyrazol-3-yl]propan-2-yl]-2-pyridinyl]-2,6-difluoro-4H-pyridin-4-ide;2,6-difluoro-3-[6-[1-[1-(2H-naphthalen-2-id-1-yl)pyrazol-3-yl]cyclopentyl]-2-pyridinyl]-4H-pyridin-4-ide;2,6-difluoro-3-[6-[1-phenyl-1-[1-[3-(trifluoromethyl)benzene-6-id-1-yl]pyrazol-3-yl]ethyl]-2-pyridinyl]-4H-pyridin-4-ide;3-[2-[6-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2-pyridinyl]propan-2-yl]-1-phenylindazole;pentakis(platinum(2+));2-(4H-pyridin-4-id-3-yl)-6-[2-[4-(trifluoromethyl)-1-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazol-3-yl]propan-2-yl]pyridine.
Molecular Properties
| Compound Name | 3-[6-[2-[1-(3H-dibenzofuran-3-id-2-yl)pyrazol-3-yl]propan-2-yl]-2-pyridinyl]-2,6-difluoro-4H-pyridin-4-ide;2,6-difluoro-3-[6-[1-[1-(2H-naphthalen-2-id-1-yl)pyrazol-3-yl]cyclopentyl]-2-pyridinyl]-4H-pyridin-4-ide;2,6-difluoro-3-[6-[1-phenyl-1-[1-[3-(trifluoromethyl)benzene-6-id-1-yl]pyrazol-3-yl]ethyl]-2-pyridinyl]-4H-pyridin-4-ide;3-[2-[6-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2-pyridinyl]propan-2-yl]-1-phenylindazole;pentakis(platinum(2+));2-(4H-pyridin-4-id-3-yl)-6-[2-[4-(trifluoromethyl)-1-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazol-3-yl]propan-2-yl]pyridine |
|---|---|
| PubChem CID | 157434277 |
| Molecular Formula | C134H89F17N20OPt5 |
| Molecular Weight | 3293.68 g/mol |
| Exact Mass | 3291.55 |
| IUPAC Name | 3-[6-[2-[1-(3H-dibenzofuran-3-id-2-yl)pyrazol-3-yl]propan-2-yl]-2-pyridinyl]-2,6-difluoro-4H-pyridin-4-ide;2,6-difluoro-3-[6-[1-[1-(2H-naphthalen-2-id-1-yl)pyrazol-3-yl]cyclopentyl]-2-pyridinyl]-4H-pyridin-4-ide;2,6-difluoro-3-[6-[1-phenyl-1-[1-[3-(trifluoromethyl)benzene-6-id-1-yl]pyrazol-3-yl]ethyl]-2-pyridinyl]-4H-pyridin-4-ide;3-[2-[6-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2-pyridinyl]propan-2-yl]-1-phenylindazole;pentakis(platinum(2+));2-(4H-pyridin-4-id-3-yl)-6-[2-[4-(trifluoromethyl)-1-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazol-3-yl]propan-2-yl]pyridine |
| SMILES | CC(C)(c1cccc(-c2[c-]cc(F)nc2F)n1)c1ccn(-c2[c-]cc3oc4ccccc4c3c2)n1.CC(C)(c1cccc(-c2[c-]cc(F)nc2F)n1)c1nn(-c2[c-]cccc2)c2ccccc12.CC(C)(c1cccc(-c2[c-]ccnc2)n1)c1nn(-c2[c-]cc(C(F)(F)F)cc2)cc1C(F)(F)F.CC(c1ccccc1)(c1cccc(-c2[c-]cc(F)nc2F)n1)c1ccn(-c2[c-]ccc(C(F)(F)F)c2)n1.Fc1c[c-]c(-c2cccc(C3(c4ccn(-c5[c-]ccc6ccccc56)n4)CCCC3)n2)c(F)n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2] |
| InChI | InChI=1S/C28H17F5N4.C28H18F2N4O.C28H20F2N4.C26H18F2N4.C24H16F6N4.5Pt/c1-27(18-7-3-2-4-8-18,23-12-6-11-22(34-23)21-13-14-25(29)35-26(21)30)24-15-16-37(36-24)20-10-5-9-19(17-20)28(31,32)33;1-28(2,24-9-5-7-21(31-24)19-11-13-26(29)32-27(19)30)25-14-15-34(33-25)17-10-12-23-20(16-17)18-6-3-4-8-22(18)35-23;29-26-14-13-21(27(30)32-26)22-10-6-12-24(31-22)28(16-3-4-17-28)25-15-18-34(33-25)23-11-5-8-19-7-1-2-9-20(19)23;1-26(2,22-14-8-12-20(29-22)18-15-16-23(27)30-25(18)28)24-19-11-6-7-13-21(19)32(31-24)17-9-4-3-5-10-17;1-22(2,20-7-3-6-19(32-20)15-5-4-12-31-13-15)21-18(24(28,29)30)14-34(33-21)17-10-8-16(9-11-17)23(25,26)27;;;;;/h2-9,11-12,14-17H,1H3;3-9,12-16H,1-2H3;1-2,5-10,12,14-15,18H,3-4,16-17H2;3-9,11-14,16H,1-2H3;3-4,6-10,12-14H,1-2H3;;;;;/q5*-2;5*+2 |
| InChIKey | MPFSOBNUCIMPSK-UHFFFAOYSA-N |
| XLogP | 31.20 |
| TPSA | 231.14 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 177 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3293.68 |
| LogP ≤ 5 | 31.20 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 21 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157434277 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.